Wang Ninghai, Satoskar Abhay, Faubion William, Howie Duncan, Okamoto Susumu, Feske Stefan, Gullo Charles, Clarke Kareem, Sosa Miriam Rodriguez, Sharpe Arlene H, Terhorst Cox
Division of Immunology, RE-204, Beth Israel Deaconess Medical Center, Harvard Medical School, 41 Avenue Louis Pasteur, Boston, MA 02215, USA.
J Exp Med. 2004 May 3;199(9):1255-64. doi: 10.1084/jem.20031835.
Signaling lymphocyte activation molecule (SLAM), a glycoprotein expressed on activated lymphocytes and antigen-presenting cells, has been shown to be a coregulator of antigen-driven T cell responses and is one of the two receptors for measles virus. Here we show that T cell receptor-induced interleukin (IL)-4 secretion by SLAM(-/-) CD4(+) cells is down-regulated, whereas interferon gamma production by CD4(+) T cells is only slightly up-regulated. Although SLAM controls production of IL-12, tumor necrosis factor, and nitric oxide in response to lipopolysaccharide (LPS) by macrophages, SLAM does not regulate phagocytosis and responses to peptidoglycan or CpG. Thus, SLAM acts as a coreceptor that regulates signals transduced by the major LPS receptor Toll-like receptor 4 on the surface of mouse macrophages. A defective macrophage function resulted in an inability of SLAM(-/-) C57Bl/6 mice to remove the parasite Leishmania major. We conclude that the coreceptor SLAM plays a central role at the interface of acquired and innate immune responses.
信号淋巴细胞激活分子(SLAM)是一种在活化淋巴细胞和抗原呈递细胞上表达的糖蛋白,已被证明是抗原驱动的T细胞反应的共调节因子,并且是麻疹病毒的两种受体之一。在这里,我们表明,SLAM(-/-)CD4(+)细胞由T细胞受体诱导的白细胞介素(IL)-4分泌下调,而CD4(+)T细胞产生的干扰素γ仅略有上调。尽管SLAM可控制巨噬细胞对脂多糖(LPS)产生的IL-12、肿瘤坏死因子和一氧化氮,但SLAM并不调节吞噬作用以及对肽聚糖或CpG的反应。因此,SLAM作为一种共受体,调节小鼠巨噬细胞表面主要LPS受体Toll样受体4转导的信号。巨噬细胞功能缺陷导致SLAM(-/-)C57Bl/6小鼠无法清除寄生虫硕大利什曼原虫。我们得出结论,共受体SLAM在获得性免疫和先天性免疫反应的界面中起核心作用。